Open Monoclonal Technology, Inc. – Trademark Portfolio
Entity Type: 03
Open Monoclonal Technology, Inc. holds 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 31 (Natural Agricultural Products) — 13 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 11 trademarks are registered. Notable registered marks include OMNIAB, OMNIRAT, OMNICLIC, OMNIFLIC, and OMNIMOUSE. The owner is based in San Diego, CA.
3911 Sorrento Valley Boulevard, Ste 110
San Diego, CA 92121
Showing of trademarks Trademarks
Trademark Classifications
Open Monoclonal Technology, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Open Monoclonal Technology, Inc. have?
Open Monoclonal Technology, Inc. has 17 U.S. trademarks filed with the USPTO. Of these, 11 registered, 2 abandoned, 4 cancelled.
What trademark classes does Open Monoclonal Technology, Inc. file in?
Open Monoclonal Technology, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 31 (Natural Agricultural Products), Class 42 (Computer & Scientific), Class 1 (Chemicals). Class 31 covers raw and unprocessed agricultural, aquacultural, horticultural and forestry products.
What are Open Monoclonal Technology, Inc.'s most well-known trademarks?
Open Monoclonal Technology, Inc.'s registered trademark portfolio includes well-known marks such as OMNIAB, OMNIRAT, OMNICLIC, OMNIFLIC, and OMNIMOUSE. These are among 11 currently registered trademarks in the portfolio.
What is Open Monoclonal Technology, Inc.'s trademark registration success rate?
Open Monoclonal Technology, Inc. has a 65% trademark registration rate, with 11 out of 17 resolved applications resulting in successful registration. Currently, 0 applications are pending review.